Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.

Rodvold KA, Gotfried MH, Isaacs RD, O'Donnell JP, Stone E.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01089-18. doi: 10.1128/AAC.01089-18. Print 2018 Nov.

PMID:
30126953
2.

Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects.

Rodvold KA, Gotfried MH, Chugh R, Gupta M, Patel A, Chavan R, Yeole R, Friedland HD, Bhatia A.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00682-18. doi: 10.1128/AAC.00682-18. Print 2018 Aug.

3.

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects.

Rizk ML, Rhee EG, Jumes PA, Gotfried MH, Zhao T, Mangin E, Bi S, Chavez-Eng CM, Zhang Z, Butterton JR.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01411-17. doi: 10.1128/AAC.01411-17. Print 2018 Mar.

4.

Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.

Rodvold KA, Gotfried MH, Chugh R, Gupta M, Yeole R, Patel A, Bhatia A.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02297-17. doi: 10.1128/AAC.02297-17. Print 2018 Mar.

5.

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.

Gotfried MH, Horn K, Garrity-Ryan L, Villano S, Tzanis E, Chitra S, Manley A, Tanaka SK, Rodvold KA.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01135-17. doi: 10.1128/AAC.01135-17. Print 2017 Sep.

6.

Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.

Rodvold KA, Gotfried MH, Chugh R, Gupta M, Friedland HD, Bhatia A.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01096-17. doi: 10.1128/AAC.01096-17. Print 2017 Sep.

7.

Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.

Wenzler E, Gotfried MH, Loutit JS, Durso S, Griffith DC, Dudley MN, Rodvold KA.

Antimicrob Agents Chemother. 2015 Dec;59(12):7232-9. doi: 10.1128/AAC.01713-15. Epub 2015 Sep 8.

8.

A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis.

Quittner AL, Marciel KK, Salathe MA, O'Donnell AE, Gotfried MH, Ilowite JS, Metersky ML, Flume PA, Lewis SA, McKevitt M, Montgomery AB, O'Riordan TG, Barker AF.

Chest. 2014 Aug;146(2):437-448. doi: 10.1378/chest.13-1891. Review. Erratum in: Chest. 2014 Nov;146(5):1422.

PMID:
24626872
9.

Role of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary disease.

Seth HD, Sultan S, Gotfried MH.

J Thorac Dis. 2013 Dec;5(6):806-14. doi: 10.3978/j.issn.2072-1439.2013.10.11. Review.

10.

Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures.

Bhattacharya I, Gotfried MH, Ji AJ, Saunders JP, Gourley I, Diehl A, Korth-Bradley JM.

J Clin Pharmacol. 2014 Jan;54(1):70-4. doi: 10.1002/jcph.201. Epub 2013 Oct 24.

PMID:
24155157
11.

The localized inflammatory response to bronchoscopic thermal vapor ablation.

Gompelmann D, Eberhardt R, Ernst A, Hopkins P, Egan J, Stanzel F, Valipour A, Wagner M, Witt C, Baker KM, Gotfried MH, Kesten S, Snell G, Herth FJ.

Respiration. 2013;86(4):324-31. doi: 10.1159/000354175. Epub 2013 Aug 23.

12.

Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis.

Justo JA, Danziger LH, Gotfried MH.

Ther Adv Respir Dis. 2013 Oct;7(5):272-87. doi: 10.1177/1753465813487412. Epub 2013 May 20. Review.

PMID:
23690368
13.

Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.

Gotfried MH, Kerwin EM, Lawrence D, Lassen C, Kramer B.

COPD. 2012 Dec;9(6):629-36. doi: 10.3109/15412555.2012.729623. Epub 2012 Sep 28.

PMID:
23020650
14.

Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema.

Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, Stanzel F, Valipour A, Wagner M, Witt C, Kesten S, Snell G.

Int J Chron Obstruct Pulmon Dis. 2012;7:397-405. doi: 10.2147/COPD.S31082. Epub 2012 Jul 18.

15.

Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.

Rodvold KA, Gotfried MH, Still JG, Clark K, Fernandes P.

Antimicrob Agents Chemother. 2012 Oct;56(10):5076-81. doi: 10.1128/AAC.00766-12. Epub 2012 Jul 16.

16.

Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.

Chandorkar G, Huntington JA, Gotfried MH, Rodvold KA, Umeh O.

J Antimicrob Chemother. 2012 Oct;67(10):2463-9. doi: 10.1093/jac/dks246. Epub 2012 Jul 6.

PMID:
22773741
17.

Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.

Kerwin EM, Gotfried MH, Lawrence D, Lassen C, Kramer B.

Clin Ther. 2011 Dec;33(12):1974-84. doi: 10.1016/j.clinthera.2011.11.009.

PMID:
22177371
18.

Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema.

Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, Valipour A, Wagner M, Stanzel F, Egan JJ, Kesten S, Ernst A.

Eur Respir J. 2012 Jun;39(6):1326-33. doi: 10.1183/09031936.00092411. Epub 2011 Nov 10.

19.

Short-course fluoroquinolones in acute exacerbations of chronic bronchitis.

Gotfried MH, Grossman RF.

Expert Rev Respir Med. 2010 Oct;4(5):661-72. doi: 10.1586/ers.10.52. Review.

PMID:
20923343
20.

Fluoroquinolones in the management of community-acquired pneumonia.

Albertson TE, Dean NC, El Solh AA, Gotfried MH, Kaplan C, Niederman MS.

Int J Clin Pract. 2010 Feb;64(3):378-88. doi: 10.1111/j.1742-1241.2009.02239.x. Review.

PMID:
20456176
21.

Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.

Gotfried MH, Shaw JP, Benton BM, Krause KM, Goldberg MR, Kitt MM, Barriere SL.

Antimicrob Agents Chemother. 2008 Jan;52(1):92-7. Epub 2007 Oct 8.

22.

Penetration of garenoxacin into lung tissues and bone in subjects undergoing lung biopsy or resection.

Krishna G, Gotfried MH, Rolston K, Wang Z.

Curr Med Res Opin. 2007 Aug;23(8):1841-7.

PMID:
17601364
23.

Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ.

J Antimicrob Chemother. 2006 Dec;58(6):1221-9. Epub 2006 Sep 29.

PMID:
17012300
24.

Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.

Sprandel KA, Schriever CA, Pendland SL, Quinn JP, Gotfried MH, Hackett S, Graham MB, Danziger LH, Rodvold KA.

Antimicrob Agents Chemother. 2004 Dec;48(12):4597-605.

25.

Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.

Gotfried MH.

Expert Rev Anti Infect Ther. 2003 Jun;1(1):9-20. Review.

PMID:
15482099
26.

Appropriate outpatient macrolide use in community-acquired pneumonia.

Gotfried MH.

J Am Acad Nurse Pract. 2004 Apr;16(4):146, 148, 150 passim. Review.

PMID:
15137473
27.

Macrolides for the treatment of chronic sinusitis, asthma, and COPD.

Gotfried MH.

Chest. 2004 Feb;125(2 Suppl):52S-60S; quiz 60S-61S. Review.

PMID:
14872001
28.

Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study.

Gotfried MH, Jung R, Messick CR, Rubinstein I, Garey KW, Rodvold KA, Danziger LH.

Curr Ther Res Clin Exp. 2004 Jan;65(1):1-12. doi: 10.1016/S0011-393X(04)90000-8.

29.

Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.

Gotfried MH, Danziger LH, Rodvold KA.

J Antimicrob Chemother. 2003 Sep;52(3):450-6. Epub 2003 Jul 29.

PMID:
12888589
30.

Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.

Rodvold KA, Danziger LH, Gotfried MH.

Antimicrob Agents Chemother. 2003 Aug;47(8):2450-7.

31.

A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.

Gotfried MH, Dattani D, Riffer E, Devcich KJ, Busman TA, Notario GF, Palmer RN.

Clin Ther. 2002 May;24(5):736-51.

PMID:
12075942
32.

Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.

Drusano GL, Preston SL, Gotfried MH, Danziger LH, Rodvold KA.

Antimicrob Agents Chemother. 2002 Feb;46(2):586-9.

33.
34.
35.
36.

Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma.

Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH.

Chest. 2000 Dec;118(6):1826-7.

PMID:
11115481
37.

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.

Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, O'Donnell A, Sahn SA, Smith LJ, Stewart JO, Abuan T, Tully H, Van Dalfsen J, Wells CD, Quan J.

Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):481-5.

PMID:
10934074
39.

Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy.

Lee LJ, Sha X, Gotfried MH, Howard JR, Dix RK, Fish DN.

Pharmacotherapy. 1998 Jan-Feb;18(1):35-41.

PMID:
9469679
40.

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.

Rodvold KA, Gotfried MH, Danziger LH, Servi RJ.

Antimicrob Agents Chemother. 1997 Jun;41(6):1399-402.

41.

An asymptomatic pleural mass in a 72-year-old man.

Gotfried MH.

Chest. 1994 Aug;106(2):572-4. No abstract available.

PMID:
7774338
42.

Penetration of clarithromycin into lung tissues from patients undergoing lung resection.

Fish DN, Gotfried MH, Danziger LH, Rodvold KA.

Antimicrob Agents Chemother. 1994 Apr;38(4):876-8.

43.
44.

Obstructive sleep apnea-pathogenesis and treatment.

Gotfried MH, Quan SF.

Lung. 1984;162(1):1-13. Review. No abstract available.

PMID:
6369007
45.

Diffuse epithelial pleural mesothelioma presenting as a solitary lung mass.

Gotfried MH, Quan SF, Sobonya RE.

Chest. 1983 Jul;84(1):99-101.

PMID:
6861552
46.

Chemoprophylaxis of tuberculosis.

Gotfried MH, Bloom J, Lebowitz MD.

Ariz Med. 1983 Mar;40(3):177-81. No abstract available.

PMID:
6860160

Supplemental Content

Loading ...
Support Center